GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Short-Term Capital Lease Obligation

NVSEF (Novartis AG) Short-Term Capital Lease Obligation : $247 Mil (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Short-Term Capital Lease Obligation?

Novartis AG's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was $247 Mil.

Novartis AG's quarterly Short-Term Capital Lease Obligation increased from Mar. 2024 ($225 Mil) to Jun. 2024 ($232 Mil) and increased from Jun. 2024 ($232 Mil) to Sep. 2024 ($247 Mil).

Novartis AG's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($275 Mil) to Dec. 2022 ($251 Mil) and declined from Dec. 2022 ($251 Mil) to Dec. 2023 ($230 Mil).

Novartis AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Novartis AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Short-Term Capital Lease Obligation Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 246.00 286.00 275.00 251.00 230.00

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.00 230.00 225.00 232.00 247.00

Novartis AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Novartis AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Novartis AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XSWX:ROG XSWX:COPN LLY OCSE:NOVO B JNJ ABBV MRK LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN
Traded in Other Exchanges
NVS:USA NVS N:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.